التفاصيل البيبلوغرافية
| العنوان: |
Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study. |
| المؤلفون: |
Lee, Hyesung, Baek, Yeon-Hee, Kim, Ju Hwan, Liao, Tzu-Chi, Lau, Wallis C Y, Man, Kenneth K C, Qin, Xiwen, Wood, Stephen, Ilomäki, Jenni, Bell, J Simon, Lai, Edward Chia-Cheng, Leung, Miriam T Y, Chan, Adrienne Y L, Chui, Celine S L, Wong, Ian C K, Shin, Ju-Young |
| المصدر: |
Age & Ageing; Feb2023, Vol. 52 Issue 2, p1-7, 7p, 1 Chart, 1 Graph |
| مصطلحات موضوعية: |
CONFIDENCE intervals, SCIENTIFIC observation, POLYPHARMACY, RETROSPECTIVE studies, DISEASE prevalence, DESCRIPTIVE statistics, DATA analysis software |
| مصطلحات جغرافية: |
AUSTRALIA, ASIA, UNITED Kingdom |
| مستخلص: |
Background Polypharmacy among older people represents a global challenge due to its association with adverse drug events. The reported prevalence of polypharmacy varies widely across countries, and is particularly high in Asian countries. However, there is no multinational study using standardised measurements exploring variations in prescribing trends. Objective To compare polypharmacy trends in older people in Asia, Australia and the United Kingdom. Design Multinational, retrospective, time-trend, observational study using a common study protocol. Setting Outpatient and community settings. Subjects All individuals aged ≥ 65 years between 2013 and 2016. Methods We defined polypharmacy as the concomitant use of ≥5 medications for ≥45 days per year. We estimated the annual prevalence of polypharmacy and calculated average annual percentage change (AAPC) to assess the time trends. Results A total of 1.62 million individuals were included in this study. The highest prevalence of polypharmacy was observed in Hong Kong (46.4%), followed by Taiwan (38.8%), South Korea (32.0%), the United Kingdom (23.5%) and Australia (20.1%) in 2016. For the time trend, the Asian region showed a steady increase, particularly in Hong Kong and South Korea (AAPC: Hong Kong, 2.7%; South Korea, 1.8%; Taiwan, 1.0%). However, Australia and the United Kingdom showed a decreasing trend (Australia, −4.9%; the United Kingdom, −1.1%). Conclusions Polypharmacy prevalence in older people was higher in Hong Kong, Taiwan and South Korea, with an increasing trend over time, compared with Australia and the United Kingdom. Our findings underline the necessity to monitor polypharmacy among older people in Asia by conducting government-level interventions and introducing medicine-optimisation strategies. [ABSTRACT FROM AUTHOR] |
|
Copyright of Age & Ageing is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder